"The US Food and Drug Administration (FDA) today approved the VisuMax Femtosecond Laser (Carl Zeiss Meditec) to remove a sliver of corneal tissue to reduce or eliminate myopia in certain adults aged 22 years or older, the agency announced today./"...
Adverse reactions include, in decreasing order of frequency, elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing.
Corticosteroid-containing preparations have also been reported to cause acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids.
The development of secondary ocular infection (bacterial, fungal and viral) has occurred. Fungal and viral infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion should be considered in any persistent corneal ulceration where steroid treatment has been used. (see WARNINGS).
Other adverse events reported with the use of FML FORTE® (fluorometholone ophthalmic suspension 0.25%) include transient burning and stinging upon instillation, ocular irritation, taste perversion and visual disturbance (blurry vision).
Read the FML Forte (fluorometholone ophthalmic suspension 0.25%) Side Effects Center for a complete guide to possible side effects
No information provided.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 7/30/2008
Additional FML Forte Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.